Publicaciones en las que colabora con Inmaculada Castilla Cortázar (26)

2019

  1. A 42-year-old woman with untreated growth hormone insensitivity, diabetic retinopathy, and gene sequencing identifies a variant of laron syndrome

    American Journal of Case Reports, Vol. 20, pp. 689-696

2017

  1. Clinical and molecular diagnosis of a cartilage-hair hypoplasia with IGF-1 deficiency

    American Journal of Medical Genetics, Part A, Vol. 173, Núm. 2, pp. 537-540

  2. Experimental approach to IGF-1 therapy in CCl4-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiency

    Journal of Translational Medicine, Vol. 15, Núm. 1

  3. Fanconi Anemia and Laron Syndrome

    American Journal of the Medical Sciences, Vol. 353, Núm. 5, pp. 425-432

  4. IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture

    Journal of Physiology and Biochemistry, Vol. 73, Núm. 2, pp. 245-258

2016

  1. Erratum: Intrauterine growth retardation (IUGR) as a novel condition of insulin-like growth factor-1 (IGF-1) deficiency (Rev Physiol Biochem Pharmacol, 10.1007/112_2015_5001)

    Reviews of Physiology, Biochemistry and Pharmacology

  2. Insulin-like growth factor-1 deficiency and metabolic syndrome

    Journal of Translational Medicine, Vol. 14, Núm. 1

  3. Intrauterine growth retardation (IUGR) as a novel condition of insulin-like growth factor-1 (IGF-1) deficiency

    Reviews of Physiology, Biochemistry and Pharmacology, Vol. 170

2006

  1. Erratum: A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury (Cytokine (2003) 22 (12-20) DOI: 10.1016/S1043-4666(03)00101-7)

    Cytokine

2005

  1. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: Results of a pilot randomized controlled clinical trial

    Journal of Hepatology, Vol. 43, Núm. 4, pp. 630-636

2004

  1. Hematotesticular barrier is altered from early stages of liver cirrhosis: Effect of insulin-like growth factor 1

    World Journal of Gastroenterology, Vol. 10, Núm. 17, pp. 2529-2534

2003

  1. A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury

    Cytokine, Vol. 22, Núm. 1-2, pp. 12-20

2002

  1. Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I

    International Journal of Biochemistry and Cell Biology, Vol. 34, Núm. 3, pp. 242-252

  2. IGF1 gene transfer into skeletal muscle using recombinant adeno-associated virus in a rat model of liver cirrhosis

    Journal of Physiology and Biochemistry, Vol. 58, Núm. 3, pp. 169-176

2001

  1. Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1536, Núm. 2-3, pp. 185-195

  2. Insulin-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats

    Liver, Vol. 21, Núm. 6, pp. 405-409

2000

  1. Altered intestinal transport of amino acids in cirrhotic rats: The effect of insulin-like growth factor-I

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 279, Núm. 2 42-2

  2. Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis

    Hepatology, Vol. 31, Núm. 3, pp. 592-600

  3. Insulin-like growth factor-I, liver function, and hypogonadism in rats with experimentally induced cirrhosis [1]

    Hepatology

1999

  1. Effect of insulin-like growth factor I on in vivo intestinal absorption of D-galactose in cirrhotic rats

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 276, Núm. 1 39-1